Global Cell Based Assay Market
Cell based assay Market is increased at a significant CAGR owing to rise in funding and investment for the R&D activities. Increase in the prevalence and incidence of chronic diseases such as cancer, drug discovery, increase in the government expenditure, and rise in the adoption of cell-based consumables by various organizations might fuel the cell-based assay market over the forecast period. Moreover, the rise in demand for biological drugs, increase the preference for toxicity screening in drugs, and reduction of cost associated with the drug discovery expected to boost the cell based assay market. However, lack of skilled professionals for conducting the cell based assays, the high cost of the instruments, and stringent regulatory policies might hinder the growth of cell based Assay market.
Cell based Assay is the analytical techniques to determine the different parameters such as biochemical or cellular functions of a living cell. Cell based Assay is used in the research of new drugs by using functional cells as diagnostic tools. The cell based Assay is commonly used to measure motility, toxicity, cell proliferation, enzyme activity, and morphology in the diagnostics and drug discovery. Cell based Assay is carried in several therapeutic areas such as cancer, stem cells, immunology, and others.
Cell based assay market segmented based on the product type, application, and end user
Based on the product type, cell based assay market segmented into the following:
- Assay Kits
- Cell growth assay
- Reporter gene assay
- Immortalized cell lines
- Stem cell lines
- Primary cell lines
Based on the application, cell based assay market segmented into the following:
- ADME studies
- Basic research
- Predictive toxicology
- Drug discovery
Based on the end user, cell-based Assay market segmented into the following
- Diagnostic Centres
- Biopharmaceutical companies
- Contract research organizations
The cell based assay market is in developing stage owing to increase in research and development for new drugs. Increase in the prevalence of various cancer diseases and immunological disorders also expected to propel the market growth. Collaborations, acquisitions & merging, and launch of new products are some of the key strategies followed by the players to increase market share. For instance, in November 2016, Axiogenesis collaborated with Metrion Biosciences Ltd to optimise, validate, and commercialize iPSC derived cell-based Assay for the new drug discovery. Investment from various companies for the R&D activities and entry of start-up companies into the market also bolster the cell based assay market growth.
Geographically, cell based assay market is segmented into, Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America expected to hold a major share in cell based assay market owing to increase in the prevalence of chronic diseases such as cancer, a rise in funding for the R&D activities, developed healthcare infrastructure, and innovation of novel drugs might propel the market growth. Europe holds a significant share in cell based assay market attributed to increase in the prevalence of chronic diseases such as cancer and immune disorders, change in lifestyle, increased healthcare expenditure, an increase in the focus of biopharmaceutical companies on the innovation of new products. Asia Pacific region is expected to grow at a significant rate due to increased investment by pharmaceutical companies, a rise in healthcare expenditure, an increase in the development of new drugs might bolster the cell based assay market over the forecast timeframe.
Some of the players in cell based assay market are PerkinElmer Inc. (U.S.), GE Healthcare (U.K), ProQinase GmbH (Germany), Danaher Corporation (U.S.), Essen BioScience Inc. (U.S.), Lonza Group (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abenex Capital SA (France), Axiogenesis AG (Germany), and Metrion Biosciences Ltd. (U.K.) to name a few.
- In July 2016, Abenex acquired the Cisbio BioAssay from Argos Soditic for developing its product portfolio
- The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments, and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario